وسيم فاضل محمد
اللقب العلمي:
قسم عن الكلية يحتوي على المعلومات والتفاصيل
رؤية الكلية، رسالتها وأهدافها الاست...
قائمة عمداء الكلية الحاليين والسابق...
أعضاء مجلس الكلية والطاقم الإداري
خريجي الكلية والمخرجات التعليمية
البحوث والمنشورات العلمية لأعضاء هي...
المناهج الأكاديمية والبرامج الدراسي...
قوانين وتشريعات ووثائق تنظيمية للكل...
خدمات وخبرات المركز الاستشاري للكلي...
مبادرات وبرامج التنمية المستدامة في...
فروع ومواقع الكلية
قسم الجراحة
قسم الطب الباطني
قسم النسائية و التوليد
قسم طب الاطفال
قسم التشريح البشري
قسم الفسلجة والفيزياء الطبية
قسم الاحياء المجهرية
وحدة العلوم الساندة
قسم الكيمياء والكيمياء الحياتية
قسم علم الامراض والطب العدلي
قسم طب الاسرة والمجتمع
فرع علم الأدوية
مجموعات عمل متخصصة بمهام محددة دائمية أو مؤقتة.
آخر أخبار الكلية
شؤون الطلبة والخدمات المرتبطة بها
اللقب العلمي:
المسمى الوظيفي:
Internal Medicine, Hematology, Hemato oncolgy,Al
Nahrain Medical College.
Specialist Internist Physician, Al-Kadhamiyia
Teaching Hospital, Deprtement of Medicine.
Practicing Hematologist. Baghdad Teaching Hospital
& National Center of Hematology.
Specialist Clinical Hematologist, Al-Kadhamiyia
Teaching Hospital, Departemnt of Medicine. Hematology unit
Consultant internist & consultant hematologist
at Imammein Kadumein medical city teaching hospital
o M.B.Ch.B 1996 MEDICAL COLLEGE, AL-NAHRAIN UNIVERSITY. o MD, DIPLOMA IN INTERNAL MEDICINE 2001 KUFA UNIVERSITY. o F.I.C.M.S.IN INTERNAL MEDICINE 2002.( IRAQI COMMITTEE OF MEDICINE) o C.A.B.M.S. IN INTERNAL MEDICINE 2004( Arab Board Committee) o F.I.B.M.S. IN CLINICAL HEMATOLOGY FOR ADULTS 2007 (IRAQI BOARD OF MEDICINE)
o Clinical teaching for 3rd,4th,5th,&6th year medical college students.(internal meidicne) o Hematology -oncology course for 4th year medical college student. o General medicine for 3rd year medical college students
o Supervisor &Trainer in internal medicine for candidates of Iraqi Board Committee of medical specialization & Arab Board committee for medical specialization o Supervisor for M.Sc. & Ph.D. students & Examining committee of M.Sc. & Ph.D. student Supervisor for postgraduate student of hemato oncology subspeciality Iraqi board candidate
1. First Presenting Feature in Patients With Bronchogenic Carcinoma.1996 (NOT PUBLISHED) 2. A Relapsed Acute Promyelocytic Leukemia Treated With Arsenic Trioxide Alone. 3. The relationship between leukocytes count & the clinical severity of presentation in patient with acute ischemic stroke. 4. Significance of Platelet Volume Indices in Patient with Coronary artery Diseases. 5. The Significance of Estimation of Anti-Apoptotic protein in Acute Leukemia Cases. 6. Influence of Thyroid Hormones on Hemoglobin A2 & F Expression. 7. Thrombotic thrombocytopenic purpura. 8. Spirometry Abnormalities in Sickle cell diseases. 9. Multiple myeloma with breast mass as extramedullary plasmacytoma.) 10. The association of radiological manifestations (by both X- ray & MRI) with the clinical presentation of multiple myeloma. 11. All Trans Retinoic Acid (ATRA) therapy in acute promyelocytic leukemia AML- M3 Results of treatment of 29 Iraqi adult patients with AML-M3 12. splenic rupture ; first manifestation of CML patient 13. USE OF recombinant human Erythropoitein in treatment of pregnancy IDA( IMJ , Dec.2012) 14. Significance of Platelet indices in Patients with acute ischemic stroke. (Iraqi journal of medical sciences, Dec. 2012)
2. A Relapsed Acute Promyelocytic Leukemia Treated With Arsenic Trioxide Alone. 3. The relationship between leukocytes count & the clinical severity of presentation in patient with acute ischemic stroke. 4. Significance of Platelet Volume Indices in Patient with Coronary artery Diseases. 5. The Significance of Estimation of Anti-Apoptotic protein in Acute Leukemia Cases. 6. Influence of Thyroid Hormones on Hemoglobin A2 & F Expression. 7. Thrombotic thrombocytopenic purpura. 8. Spirometry Abnormalities in Sickle cell diseases. 9. Multiple myeloma with breast mass as extramedullary plasmacytoma.) 10. The association of radiological manifestations (by both X- ray & MRI) with the clinical presentation of multiple myeloma. 11. All Trans Retinoic Acid (ATRA) therapy in acute promyelocytic leukemia AML- M3 Results of treatment of 29 Iraqi adult patients with AML-M3 12. splenic rupture ; first manifestation of CML patient 13. USE OF recombinant human Erythropoitein in treatment of pregnancy IDA( IMJ , Dec.2012) 14. Significance of Platelet indices in Patients with acute ischemic stroke. (Iraqi journal of medical sciences, Dec. 2012)